Skip navigation

Chemical Androstanols

1–50 of 127 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. Dihydrotestosterone androgen biosynthetic process 17-(5'-isoxazolyl)androsta-4,16-dien-3-one [17-(5'-isoxazolyl)androsta-4,16-dien-3-one results in decreased androgen biosynthetic process] which results in decreased chemical synthesis of Dihydrotestosterone 1: Homo sapiens Prostate | Cell Line, Tumor
5 genes: HSD17B6 | HSD3B1 | SRD5A1 | SRD5A2 | SRD5A3
1
2. Dihydrotestosterone androgen biosynthetic process 4,16-androstadien-3-one [4,16-androstadien-3-one analog results in decreased androgen biosynthetic process] which results in decreased chemical synthesis of Dihydrotestosterone 1: Homo sapiens Prostate | Cell Line, Tumor
5 genes: HSD17B6 | HSD3B1 | SRD5A1 | SRD5A2 | SRD5A3
1
3. Dihydrotestosterone regulation of cell size Dihydrotestosterone affects regulation of cell size 1: Rattus norvegicus Anterior Horn Cells | Motor Neurons
3 genes: CREB1 | PTEN | RARG
1
4. Dihydrotestosterone positive regulation of cell proliferation prochloraz prochloraz inhibits the reaction [Dihydrotestosterone results in increased positive regulation of cell proliferation] 1: Homo sapiens Prostate | Cell Line, Tumor
62 genes: ADM | AGT | AKR1C2 | AKR1C3 | AKT1 | AR | ATF3 | BCL2 | BCL2L1 | CCND1 | CDC20 | CDK2 | CDKN1B | CHRM1 | CLU | CSF1 | CSF2 | CSNK2A1 | CXCL12 | EMP2 | EPOR | F2R | FABP4 | FGF2 | FGFR1 | FOSL1 | FSHB | ID2 | ID3 | ID4 | IGF1 | IGF1R | IL6 | IL7 | ITGB1 | KITLG | LEP | MAPK1 | MIR1290 | MIR200B | MIR21 | MYC | NANOG | NCOR1 | NKX3-1 | PRKAA1 | PRL | PRL2C3 | PTEN | PTGS2 | PTHLH | PTN | PURA | RARG | S100B | SMARCA4 | TCIRG1 | TGFB1 | THBS1 | TNF | VEGFA | VEGFD
1
5. Dihydrotestosterone negative regulation of androgen receptor activity Aldrin [Aldrin results in increased negative regulation of androgen receptor activity] which results in decreased susceptibility to Dihydrotestosterone 1: Homo sapiens Osteoblasts | Cell Line, Tumor   1
6. Dihydrotestosterone cell proliferation EPI 001 EPI 001 inhibits the reaction [Dihydrotestosterone results in increased cell proliferation] 1: Homo sapiens Prostate | Cell Line, Tumor
42 genes: AKT1 | AR | BAX | BCAR1 | BCL2 | BCL2L1 | BUB1B | CHRM1 | CREBBP | CSF1 | CXCL1 | DAZAP1 | EMP1 | EMP2 | ERG | FGF2 | GAS6 | ID4 | IGF1 | INSIG1 | KITLG | LAMA5 | LIPG | MAP2K1 | MIF | MYC | NANOG | PA2G4 | PCNA | PIM1 | PRL | PTEN | PURA | S100B | SKP2 | SMAD4 | SRC | TGFB1 | TNF | TP53 | VEGFA | VEGFD
1
7. Dihydrotestosterone negative regulation of androgen receptor activity 2,3',4,4',5-pentachlorobiphenyl [2,3',4,4',5-pentachlorobiphenyl results in increased negative regulation of androgen receptor activity] which results in decreased susceptibility to Dihydrotestosterone 1: Homo sapiens Osteoblasts | Cell Line, Tumor   1
8. Dihydrotestosterone cell proliferation bis(4-hydroxyphenyl)sulfone bis(4-hydroxyphenyl)sulfone inhibits the reaction [Dihydrotestosterone results in increased cell proliferation] 1: Homo sapiens Prostate | Cell Line, Tumor
42 genes: AKT1 | AR | BAX | BCAR1 | BCL2 | BCL2L1 | BUB1B | CHRM1 | CREBBP | CSF1 | CXCL1 | DAZAP1 | EMP1 | EMP2 | ERG | FGF2 | GAS6 | ID4 | IGF1 | INSIG1 | KITLG | LAMA5 | LIPG | MAP2K1 | MIF | MYC | NANOG | PA2G4 | PCNA | PIM1 | PRL | PTEN | PURA | S100B | SKP2 | SMAD4 | SRC | TGFB1 | TNF | TP53 | VEGFA | VEGFD
1
9. Dihydrotestosterone negative regulation of androgen receptor activity Pesticides [Pesticides results in increased negative regulation of androgen receptor activity] which results in decreased susceptibility to Dihydrotestosterone 1: Homo sapiens Osteoblasts | Cell Line, Tumor   1
10. Dihydrotestosterone negative regulation of androgen receptor activity Lindane [Lindane results in increased negative regulation of androgen receptor activity] which results in decreased susceptibility to Dihydrotestosterone 1: Homo sapiens Osteoblasts | Cell Line, Tumor   1
11. Dihydrotestosterone positive regulation of cell proliferation 20-hydroximino-4,16-pregnadien-3-one 20-hydroximino-4,16-pregnadien-3-one inhibits the reaction [Dihydrotestosterone results in increased positive regulation of cell proliferation] 1: Homo sapiens Prostate | Cell Line, Tumor
62 genes: ADM | AGT | AKR1C2 | AKR1C3 | AKT1 | AR | ATF3 | BCL2 | BCL2L1 | CCND1 | CDC20 | CDK2 | CDKN1B | CHRM1 | CLU | CSF1 | CSF2 | CSNK2A1 | CXCL12 | EMP2 | EPOR | F2R | FABP4 | FGF2 | FGFR1 | FOSL1 | FSHB | ID2 | ID3 | ID4 | IGF1 | IGF1R | IL6 | IL7 | ITGB1 | KITLG | LEP | MAPK1 | MIR1290 | MIR200B | MIR21 | MYC | NANOG | NCOR1 | NKX3-1 | PRKAA1 | PRL | PRL2C3 | PTEN | PTGS2 | PTHLH | PTN | PURA | RARG | S100B | SMARCA4 | TCIRG1 | TGFB1 | THBS1 | TNF | VEGFA | VEGFD
1
12. Dihydrotestosterone androgen receptor signaling pathway Dihydrotestosterone results in increased androgen receptor signaling pathway 1: Homo sapiens Mesenchymal Stromal Cells | Cell Line, Tumor
11 genes: AR | CCNE1 | FHL2 | NCOA1 | NCOA3 | NCOA4 | NKX3-1 | NR1I3 | PMEPA1 | RB1 | SCGB2A1
1
13. Dihydrotestosterone positive regulation of cell proliferation Pregnadienes Pregnadienes analog inhibits the reaction [Dihydrotestosterone results in increased positive regulation of cell proliferation] 1: Homo sapiens Prostate | Cell Line, Tumor
62 genes: ADM | AGT | AKR1C2 | AKR1C3 | AKT1 | AR | ATF3 | BCL2 | BCL2L1 | CCND1 | CDC20 | CDK2 | CDKN1B | CHRM1 | CLU | CSF1 | CSF2 | CSNK2A1 | CXCL12 | EMP2 | EPOR | F2R | FABP4 | FGF2 | FGFR1 | FOSL1 | FSHB | ID2 | ID3 | ID4 | IGF1 | IGF1R | IL6 | IL7 | ITGB1 | KITLG | LEP | MAPK1 | MIR1290 | MIR200B | MIR21 | MYC | NANOG | NCOR1 | NKX3-1 | PRKAA1 | PRL | PRL2C3 | PTEN | PTGS2 | PTHLH | PTN | PURA | RARG | S100B | SMARCA4 | TCIRG1 | TGFB1 | THBS1 | TNF | VEGFA | VEGFD
1
14. Dihydrotestosterone negative regulation of androgen receptor activity Dieldrin [Dieldrin results in increased negative regulation of androgen receptor activity] which results in decreased susceptibility to Dihydrotestosterone 1: Homo sapiens Osteoblasts | Cell Line, Tumor   1
15. Dihydrotestosterone negative regulation of androgen receptor activity Toxaphene [Toxaphene results in increased negative regulation of androgen receptor activity] which results in decreased susceptibility to Dihydrotestosterone 1: Homo sapiens Osteoblasts | Cell Line, Tumor   1
16. Dihydrotestosterone negative regulation of androgen receptor activity PCB 180 [PCB 180 results in increased negative regulation of androgen receptor activity] which results in decreased susceptibility to Dihydrotestosterone 1: Homo sapiens Osteoblasts | Cell Line, Tumor   1
17. Dihydrotestosterone androgen metabolic process bicalutamide | Dutasteride | Goserelin | Ketoconazole [[Goserelin co-treated with Dutasteride co-treated with bicalutamide co-treated with Ketoconazole] affects androgen metabolic process] which results in decreased abundance of Dihydrotestosterone 1: Homo sapiens Serum
9 genes: ADM | AKR1C4 | CYP19A1 | ESR1 | HSD17B1 | HSD17B6 | NR3C1 | SRD5A1 | SRD5A2
1
18. Dihydrotestosterone androgen receptor signaling pathway Butylated Hydroxyanisole | Butylated Hydroxytoluene [Butylated Hydroxyanisole co-treated with Butylated Hydroxytoluene] inhibits the reaction [Dihydrotestosterone results in increased androgen receptor signaling pathway] 1: Homo sapiens Mammary Glands, Human | Epithelial Cells | Cell Line, Tumor
11 genes: AR | CCNE1 | FHL2 | NCOA1 | NCOA3 | NCOA4 | NKX3-1 | NR1I3 | PMEPA1 | RB1 | SCGB2A1
1
19. Dihydrotestosterone androgen receptor signaling pathway butylparaben butylparaben inhibits the reaction [Dihydrotestosterone results in increased androgen receptor signaling pathway] 1: Homo sapiens Mammary Glands, Human | Epithelial Cells | Cell Line, Tumor
11 genes: AR | CCNE1 | FHL2 | NCOA1 | NCOA3 | NCOA4 | NKX3-1 | NR1I3 | PMEPA1 | RB1 | SCGB2A1
1
20. Dihydrotestosterone androgen biosynthetic process Pregnadienes [Pregnadienes analog results in decreased androgen biosynthetic process] which results in decreased chemical synthesis of Dihydrotestosterone 1: Homo sapiens Prostate | Cell Line, Tumor
5 genes: HSD17B6 | HSD3B1 | SRD5A1 | SRD5A2 | SRD5A3
1
21. Dihydrotestosterone negative regulation of androgen receptor activity Chlordan [Chlordan results in increased negative regulation of androgen receptor activity] which results in decreased susceptibility to Dihydrotestosterone 1: Homo sapiens Osteoblasts | Cell Line, Tumor   1
22. Dihydrotestosterone androgen metabolic process bicalutamide | Goserelin [[Goserelin co-treated with bicalutamide] affects androgen metabolic process] which results in decreased abundance of Dihydrotestosterone 1: Homo sapiens Serum
9 genes: ADM | AKR1C4 | CYP19A1 | ESR1 | HSD17B1 | HSD17B6 | NR3C1 | SRD5A1 | SRD5A2
1
23. Dihydrotestosterone negative regulation of androgen receptor activity DDT [DDT results in increased negative regulation of androgen receptor activity] which results in decreased susceptibility to Dihydrotestosterone 1: Homo sapiens Osteoblasts | Cell Line, Tumor   1
24. Dihydrotestosterone androgen receptor signaling pathway Dihydrotestosterone results in increased androgen receptor signaling pathway 1: Homo sapiens Osteoblasts | Cell Line, Tumor
11 genes: AR | CCNE1 | FHL2 | NCOA1 | NCOA3 | NCOA4 | NKX3-1 | NR1I3 | PMEPA1 | RB1 | SCGB2A1
1
25. Dihydrotestosterone locomotory behavior Dihydrotestosterone affects locomotory behavior 1: Danio rerio  
13 genes: ALDH1A3 | APP | ATP7A | COL6A1 | DBH | FSHR | GAA | HPRT1 | PTEN | RACK1 | SELENOP | SOD2 | TH
1
26. Dihydrotestosterone negative regulation of androgen receptor activity Dichlorodiphenyl Dichloroethylene [Dichlorodiphenyl Dichloroethylene results in increased negative regulation of androgen receptor activity] which results in decreased susceptibility to Dihydrotestosterone 1: Homo sapiens Osteoblasts | Cell Line, Tumor   1
27. Dihydrotestosterone positive regulation of superoxide dismutase activity Dihydrotestosterone results in increased positive regulation of superoxide dismutase activity 1: Rattus norvegicus Ovary 1 gene: TNF 1
28. Dihydrotestosterone negative regulation of androgen receptor activity Dichlorodiphenyldichloroethane [Dichlorodiphenyldichloroethane results in increased negative regulation of androgen receptor activity] which results in decreased susceptibility to Dihydrotestosterone 1: Homo sapiens Osteoblasts | Cell Line, Tumor   1
29. Dihydrotestosterone negative regulation of androgen receptor activity Benzo(a)pyrene [Benzo(a)pyrene results in increased negative regulation of androgen receptor activity] which results in decreased susceptibility to Dihydrotestosterone 1: Homo sapiens Osteoblasts | Cell Line, Tumor   1
30. Dihydrotestosterone positive regulation of cell proliferation bicalutamide bicalutamide inhibits the reaction [Dihydrotestosterone results in increased positive regulation of cell proliferation] 1: Homo sapiens Prostate | Cell Line, Tumor
62 genes: ADM | AGT | AKR1C2 | AKR1C3 | AKT1 | AR | ATF3 | BCL2 | BCL2L1 | CCND1 | CDC20 | CDK2 | CDKN1B | CHRM1 | CLU | CSF1 | CSF2 | CSNK2A1 | CXCL12 | EMP2 | EPOR | F2R | FABP4 | FGF2 | FGFR1 | FOSL1 | FSHB | ID2 | ID3 | ID4 | IGF1 | IGF1R | IL6 | IL7 | ITGB1 | KITLG | LEP | MAPK1 | MIR1290 | MIR200B | MIR21 | MYC | NANOG | NCOR1 | NKX3-1 | PRKAA1 | PRL | PRL2C3 | PTEN | PTGS2 | PTHLH | PTN | PURA | RARG | S100B | SMARCA4 | TCIRG1 | TGFB1 | THBS1 | TNF | VEGFA | VEGFD
1
31. Dihydrotestosterone androgen receptor signaling pathway Butylated Hydroxyanisole Butylated Hydroxyanisole inhibits the reaction [Dihydrotestosterone results in increased androgen receptor signaling pathway] 1: Homo sapiens Mammary Glands, Human | Epithelial Cells | Cell Line, Tumor
11 genes: AR | CCNE1 | FHL2 | NCOA1 | NCOA3 | NCOA4 | NKX3-1 | NR1I3 | PMEPA1 | RB1 | SCGB2A1
1
32. Dihydrotestosterone androgen metabolic process bicalutamide | Dutasteride | Goserelin [[Goserelin co-treated with Dutasteride co-treated with bicalutamide] affects androgen metabolic process] which results in decreased abundance of Dihydrotestosterone 1: Homo sapiens Serum
9 genes: ADM | AKR1C4 | CYP19A1 | ESR1 | HSD17B1 | HSD17B6 | NR3C1 | SRD5A1 | SRD5A2
1
33. Dihydrotestosterone neurogenesis Flutamide Flutamide inhibits the reaction [Dihydrotestosterone results in increased neurogenesis] 1: Danio rerio Embryonic Structures | Hypothalamus
6 genes: CDK5RAP2 | FGF2 | MYC | PHGDH | PSEN1 | SMARCA4
1
34. Dihydrotestosterone cell proliferation Curcumin Curcumin inhibits the reaction [Dihydrotestosterone results in increased cell proliferation] 1: Homo sapiens Prostate | Cell Line, Tumor
42 genes: AKT1 | AR | BAX | BCAR1 | BCL2 | BCL2L1 | BUB1B | CHRM1 | CREBBP | CSF1 | CXCL1 | DAZAP1 | EMP1 | EMP2 | ERG | FGF2 | GAS6 | ID4 | IGF1 | INSIG1 | KITLG | LAMA5 | LIPG | MAP2K1 | MIF | MYC | NANOG | PA2G4 | PCNA | PIM1 | PRL | PTEN | PURA | S100B | SKP2 | SMAD4 | SRC | TGFB1 | TNF | TP53 | VEGFA | VEGFD
1
35. Dihydrotestosterone androgen receptor signaling pathway Butylated Hydroxytoluene | butylparaben [butylparaben co-treated with Butylated Hydroxytoluene] inhibits the reaction [Dihydrotestosterone results in increased androgen receptor signaling pathway] 1: Homo sapiens Mammary Glands, Human | Epithelial Cells | Cell Line, Tumor
11 genes: AR | CCNE1 | FHL2 | NCOA1 | NCOA3 | NCOA4 | NKX3-1 | NR1I3 | PMEPA1 | RB1 | SCGB2A1
1
36. Dihydrotestosterone cell cycle Dihydrotestosterone results in decreased cell cycle 1: Homo sapiens Prostate | Epithelial Cells | Cell Line
38 genes: AHR | ANKLE2 | BUB1B | CCNA2 | CCNB1 | CCNB2 | CCND1 | CCNE1 | CDC20 | CDK2 | CDKN1A | CDKN1B | CGREF1 | CHEK2 | CSNK2A1 | DCLRE1A | E2F1 | EP300 | KLHL42 | MAPK1 | MAPK3 | MAPK6 | MCM5 | MYOG | NCAPD3 | NR3C1 | PIM1 | PKMYT1 | RACK1 | RAD21 | RAD50 | RB1 | RPS6KB1 | SPECC1LA | SRC | TP53 | TRIOBP | TSG101
1
37. Dihydrotestosterone apoptotic process Dihydrotestosterone results in decreased apoptotic process 1: Homo sapiens Ovary | Cells, Cultured
46 genes: AHR | AKT1 | APP | BAX | BCL2 | BCL2L1 | BCL2L13 | BIRC2 | BUB1B | CASP3 | CASP7 | CGB3 | CHEK2 | CIDEA | CSNK2A1 | DHCR24 | DYNLL1 | E2F1 | EGLN3 | EP300 | GAPDH | GAS6 | IGFBP3 | MAPK1 | MAPK14 | MAPK3 | MEF2A | MEF2C | NR3C1 | PEA15 | PHLDA1 | PIDD1 | PIM1 | PSEN1 | PTEN | PURA | RACK1 | RAD21 | RB1 | RHBDD1 | RPS6KB1 | STK17B | STPG1 | TNF | TNFRSF11B | TP53
1
38. Dihydrotestosterone cell proliferation Dihydrotestosterone results in increased cell proliferation 1: Homo sapiens Prostate | Epithelial Cells | Cell Line, Tumor
42 genes: AKT1 | AR | BAX | BCAR1 | BCL2 | BCL2L1 | BUB1B | CHRM1 | CREBBP | CSF1 | CXCL1 | DAZAP1 | EMP1 | EMP2 | ERG | FGF2 | GAS6 | ID4 | IGF1 | INSIG1 | KITLG | LAMA5 | LIPG | MAP2K1 | MIF | MYC | NANOG | PA2G4 | PCNA | PIM1 | PRL | PTEN | PURA | S100B | SKP2 | SMAD4 | SRC | TGFB1 | TNF | TP53 | VEGFA | VEGFD
1
39. Dihydrotestosterone cellular hypotonic response positive regulation of cell volume [Dihydrotestosterone results in decreased cellular hypotonic response] which results in decreased positive regulation of cell volume 1: Homo sapiens Granulosa Cells | Cells, Cultured 1 gene: STK39 1
40. Dihydrotestosterone positive regulation of cell migration Dihydrotestosterone results in increased positive regulation of cell migration 1: Homo sapiens Prostate | Cell Line, Tumor
24 genes: ABCC1 | BCAR1 | CDH13 | COL1A1 | CSF1 | CXCL12 | F2R | FSHB | IGF1 | IGF1R | ITGB1 | MAP2K1 | MAPK1 | MIR1290 | MIR21 | MMP3 | RACK1 | SMAD3 | SNAI1 | SNAI2 | SOD2 | TGFB1 | THBS1 | VEGFA
1
41. Dihydrotestosterone lipid catabolic process Colforsin Dihydrotestosterone promotes the reaction [Colforsin results in increased lipid catabolic process] 1: Homo sapiens Adipocytes
5 genes: APOC2 | LIPG | LPL | PLCD3A | RAB7A
1
42. Dihydrotestosterone apoptotic process Curcumin | Quercetin Dihydrotestosterone inhibits the reaction [Curcumin promotes the reaction [Quercetin results in increased apoptotic process]] 1: Homo sapiens Pancreas | Cell Line, Tumor
46 genes: AHR | AKT1 | APP | BAX | BCL2 | BCL2L1 | BCL2L13 | BIRC2 | BUB1B | CASP3 | CASP7 | CGB3 | CHEK2 | CIDEA | CSNK2A1 | DHCR24 | DYNLL1 | E2F1 | EGLN3 | EP300 | GAPDH | GAS6 | IGFBP3 | MAPK1 | MAPK14 | MAPK3 | MEF2A | MEF2C | NR3C1 | PEA15 | PHLDA1 | PIDD1 | PIM1 | PSEN1 | PTEN | PURA | RACK1 | RAD21 | RB1 | RHBDD1 | RPS6KB1 | STK17B | STPG1 | TNF | TNFRSF11B | TP53
1
43. Dihydrotestosterone positive regulation of glutathione peroxidase activity Dihydrotestosterone results in decreased positive regulation of glutathione peroxidase activity 1: Rattus norvegicus Ovary   1
44. Dihydrotestosterone apoptotic process APP Dihydrotestosterone inhibits the reaction [APP protein modified form results in increased apoptotic process] 1: Rattus norvegicus Hippocampus | Neurons | Cells, Cultured
46 genes: AHR | AKT1 | APP | BAX | BCL2 | BCL2L1 | BCL2L13 | BIRC2 | BUB1B | CASP3 | CASP7 | CGB3 | CHEK2 | CIDEA | CSNK2A1 | DHCR24 | DYNLL1 | E2F1 | EGLN3 | EP300 | GAPDH | GAS6 | IGFBP3 | MAPK1 | MAPK14 | MAPK3 | MEF2A | MEF2C | NR3C1 | PEA15 | PHLDA1 | PIDD1 | PIM1 | PSEN1 | PTEN | PURA | RACK1 | RAD21 | RB1 | RHBDD1 | RPS6KB1 | STK17B | STPG1 | TNF | TNFRSF11B | TP53
1
45. Dihydrotestosterone negative regulation of androgen receptor activity beta-hexachlorocyclohexane [beta-hexachlorocyclohexane results in increased negative regulation of androgen receptor activity] which results in decreased susceptibility to Dihydrotestosterone 1: Homo sapiens Osteoblasts | Cell Line, Tumor   1
46. Dihydrotestosterone positive regulation of glutathione peroxidase activity resveratrol resveratrol inhibits the reaction [Dihydrotestosterone results in decreased positive regulation of glutathione peroxidase activity] 1: Rattus norvegicus Ovary   1
47. Dihydrotestosterone negative regulation of androgen receptor activity Soil Pollutants [Soil Pollutants results in increased negative regulation of androgen receptor activity] which results in decreased susceptibility to Dihydrotestosterone 1: Homo sapiens Osteoblasts | Cell Line, Tumor   1
48. Dihydrotestosterone negative regulation of androgen receptor activity Endrin [Endrin results in increased negative regulation of androgen receptor activity] which results in decreased susceptibility to Dihydrotestosterone 1: Homo sapiens Osteoblasts | Cell Line, Tumor   1
49. Dihydrotestosterone positive regulation of cell proliferation androsta-5,16-dien-3 beta-ol androsta-5,16-dien-3 beta-ol analog inhibits the reaction [Dihydrotestosterone results in increased positive regulation of cell proliferation] 1: Homo sapiens Prostate | Cell Line, Tumor
62 genes: ADM | AGT | AKR1C2 | AKR1C3 | AKT1 | AR | ATF3 | BCL2 | BCL2L1 | CCND1 | CDC20 | CDK2 | CDKN1B | CHRM1 | CLU | CSF1 | CSF2 | CSNK2A1 | CXCL12 | EMP2 | EPOR | F2R | FABP4 | FGF2 | FGFR1 | FOSL1 | FSHB | ID2 | ID3 | ID4 | IGF1 | IGF1R | IL6 | IL7 | ITGB1 | KITLG | LEP | MAPK1 | MIR1290 | MIR200B | MIR21 | MYC | NANOG | NCOR1 | NKX3-1 | PRKAA1 | PRL | PRL2C3 | PTEN | PTGS2 | PTHLH | PTN | PURA | RARG | S100B | SMARCA4 | TCIRG1 | TGFB1 | THBS1 | TNF | VEGFA | VEGFD
1
50. Dihydrotestosterone androgen biosynthetic process androsta-5,16-dien-3 beta-ol [androsta-5,16-dien-3 beta-ol analog results in decreased androgen biosynthetic process] which results in decreased chemical synthesis of Dihydrotestosterone 1: Homo sapiens Prostate | Cell Line, Tumor
5 genes: HSD17B6 | HSD3B1 | SRD5A1 | SRD5A2 | SRD5A3
1
1–50 of 127 results.